Sponsor Dossier
Haleon
Sponsor Dossier for Haleon. ARTG portfolio, PBS-listed brands, PBAC activity, AusPAR record — compiled by arcimedes.
- Brand: ADVIL
- Brand: ADVILDUO
- Brand: Aquaear
- Brand: AURALGAN
- Brand: Caltrate
- Brand: Centrum
- Brand: COMBIMOL
- Brand: DE-GAS
- Device (sponsor): Dentifrice
- Device (sponsor): Dentifrice
- Device (sponsor): Denture cleanser
- Device (sponsor): Dentifrice
- Device (sponsor): Dentifrice
- Device (sponsor): Nasal irrigation saline solution, non-sterile
About
Haleon is an Australian Private Company with ABN 68 603 310 292, registered in Victoria. The company adopted the trading name Haleon from 22 June 2022, having previously operated under the business name GlaxoSmithKline Consumer Healthcare. Haleon is currently active on the Australian Business Register.
Portfolio
Haleon maintains a portfolio of 23 brands on the ARTG, of which 5 are indexable brands that have cleared the SEO quality gate. Four brands have Product Information on file, one brand is PBS-listed, and one brand has PBAC outcome records. Notable brands in the portfolio include ADVIL, ADVILDUO, Aquaear, AURALGAN, Caltrate, Centrum, COMBIMOL, DE-GAS, DONNATAB, ENO, FLIXONASE, and HYDROZOLE.
Therapeutic focus
The portfolio is distributed across the following therapeutic areas: — Pain Management: 4 brands — Gastroenterology: 4 brands — Respiratory: 3 brands — Complementary Medicine: 3 brands — Pain & Anaesthesia: 3 brands — Infectious Disease: 3 brands — Musculoskeletal: 1 brand — Women's Health: 1 brand — Other: 1 brand
PBS footprint
One brand in the Haleon portfolio holds at least one PBS-listed item, with the portfolio most recently touching the PBS schedule on 1 May 2026.
Regulatory activity
The most recent PBAC outcome on record for Haleon is dated 1 March 2019, representing a single brand with PBAC outcome history.